Roche's Small Spark Deal Holds a Big Regulatory Warning

Bookmark
(Bloomberg Opinion) -- Roche Holding AG’s $4.7 billion purchase of gene-therapy developer Spark Therapeutics Inc. finally closed Tuesday after a 10-month regulatory saga. Many industries would shru...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.